Physician profile
Guy T Burrows
NPI 1821075060
$2,938.81
in general payments reported to CMS, 2019-2025
26 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.18 · 2021: $124 · 2022: $573 · 2023: $848 · 2024: $680 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.00 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $1,224.01 | 2022-2025 | Gamunex-C, Prolastin-C Liquid |
| Abbvie INC. | $311.21 | 2021-2025 | Botox |
| Takeda Pharmaceuticals U.S.A., INC. | $160.81 | 2021-2025 | Hyqvia |
| Biogen, INC. | $160.68 | 2020-2023 | Spinraza |
| Argenx US, INC. | $137.62 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $128.47 | 2022-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $117.68 | 2025 | |
| Ucb, INC. | $114.52 | 2023-2025 | Rystiggo |
| Catalyst Pharmaceuticals, INC. | $88.91 | 2022 | |
| Ge Healthcare | $81.93 | 2023-2024 | |
| Genzyme Corporation | $57.55 | 2023-2024 | |
| Janssen Biotech, INC. | $56.95 | 2025 | |
| Pfizer INC. | $46.05 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $31.91 | 2020 | |
| Boston Scientific Corporation | $31.28 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $28.11 | 2023 | Watchpatone |
| Xeris Pharmaceuticals, INC. | $21.58 | 2022 | |
| Genentech USA, INC. | $20.76 | 2021 | |
| Curonix LLC | $20.42 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bio Products Laboratory USA, INC. | $18.37 | 2023 | Gammaplex, Coagadex |
| Kedrion Biopharma, INC. | $15.51 | 2025 | Koate, Kedrab, Gammaked |
| Eisai INC. | $13.99 | 2020 | |
| Upsher-Smith Laboratories LLC | $13.61 | 2021 | |
| Medtronic, INC. | $12.71 | 2023 | Intellis Adaptivestim |
| Neurocrine Biosciences, INC. | $12.42 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Burrows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.